Gilead Sciences to Present at the 22nd Annual Piper Jaffray Healthcare Conference on Tuesday, November 30

Webcast Available Through Gilead Corporate Website

FOSTER CITY, Calif., Nov 23, 2010 (BUSINESS WIRE) -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the 22nd Annual Piper Jaffray Healthcare Conference in New York.

John F. Milligan, PhD, Gilead's President and Chief Operating Officer, will provide an overview of the company on Tuesday, November 30 at 9:30 a.m. Eastern Standard Time.

To access the live webcast via the Internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the live presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

SOURCE: Gilead Sciences, Inc.

Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715 (Investor Relations)